AAPL   381.57 (-0.30%)
MSFT   213.18 (-0.53%)
GOOGL   1,522.20 (+0.23%)
AMZN   3,184.58 (+0.06%)
CGC   16.97 (+5.93%)
BABA   259.28 (-0.88%)
MU   50.02 (+0.08%)
GE   6.67 (+1.37%)
TSLA   1,492.82 (+7.07%)
F   6.04 (+3.25%)
GILD   76.31 (+2.14%)
DIS   118.94 (+1.81%)
BAC   23.90 (+4.96%)
NFLX   550.15 (+8.35%)
BA   178.44 (+2.98%)
AAPL   381.57 (-0.30%)
MSFT   213.18 (-0.53%)
GOOGL   1,522.20 (+0.23%)
AMZN   3,184.58 (+0.06%)
CGC   16.97 (+5.93%)
BABA   259.28 (-0.88%)
MU   50.02 (+0.08%)
GE   6.67 (+1.37%)
TSLA   1,492.82 (+7.07%)
F   6.04 (+3.25%)
GILD   76.31 (+2.14%)
DIS   118.94 (+1.81%)
BAC   23.90 (+4.96%)
NFLX   550.15 (+8.35%)
BA   178.44 (+2.98%)
AAPL   381.57 (-0.30%)
MSFT   213.18 (-0.53%)
GOOGL   1,522.20 (+0.23%)
AMZN   3,184.58 (+0.06%)
CGC   16.97 (+5.93%)
BABA   259.28 (-0.88%)
MU   50.02 (+0.08%)
GE   6.67 (+1.37%)
TSLA   1,492.82 (+7.07%)
F   6.04 (+3.25%)
GILD   76.31 (+2.14%)
DIS   118.94 (+1.81%)
BAC   23.90 (+4.96%)
NFLX   550.15 (+8.35%)
BA   178.44 (+2.98%)
AAPL   381.57 (-0.30%)
MSFT   213.18 (-0.53%)
GOOGL   1,522.20 (+0.23%)
AMZN   3,184.58 (+0.06%)
CGC   16.97 (+5.93%)
BABA   259.28 (-0.88%)
MU   50.02 (+0.08%)
GE   6.67 (+1.37%)
TSLA   1,492.82 (+7.07%)
F   6.04 (+3.25%)
GILD   76.31 (+2.14%)
DIS   118.94 (+1.81%)
BAC   23.90 (+4.96%)
NFLX   550.15 (+8.35%)
BA   178.44 (+2.98%)
Log in

NASDAQ:RIGLRigel Pharmaceuticals Insider Trades

$1.82
0.00 (0.00 %)
(As of 07/10/2020 02:36 PM ET)
Add
Compare
Today's Range
$1.79
Now: $1.82
$1.85
50-Day Range
$1.78
MA: $1.89
$2.05
52-Week Range
$1.23
Now: $1.82
$3.10
Volume27,341 shs
Average Volume2.08 million shs
Market Capitalization$306.80 million
P/E RatioN/A
Dividend YieldN/A
Beta1.26

Insider Trades

Rigel Pharmaceuticals (NASDAQ:RIGL) Insider Buying and Selling Activity

Insider Ownership Percentage: 4.72%

Insider Buying and Selling by Quarter


Rigel Pharmaceuticals (NASDAQ RIGL) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/22/2019Dean L SchornoCFOBuy50,000$2.13$106,500.0046,726  
10/12/2018Nelson CabatuanInsiderSell10,000$3.12$31,200.0058  
9/17/2018Anne-Marie DuliegeEVPSell153,000$3.50$535,500.00115,500  
9/11/2018Eldon C Mayer IIIEVPBuy100,000$3.26$326,000.00165,000  
9/4/2018Anne-Marie DuliegeEVPSell16,500$3.51$57,915.0016,500  
8/23/2018Eldon C. Mayer IIIEVPBuy100,000$2.82$282,000.00  
8/17/2018Raul R. RodriguezCEOBuy114,000$2.63$299,820.00  
7/2/2018Anne-Marie DuliegeEVPSell5,000$2.79$13,950.00  
4/20/2018Anne-Marie DuliegeEVPSell5,000$4.11$20,550.00  
11/3/2017Ryan D MaynardCFOSell100,000$3.90$390,000.00100,000  
7/5/2017Anne-Marie DuliegeInsiderSell5,000$2.69$13,450.00  
8/30/2016Donald G PayanEVPSell5,303$4.00$21,212.00  
4/1/2015Donald G PayanEVPSell10,000$3.75$37,500.00  
12/18/2014Dolly VanceEVPSell1,000$2.22$2,220.00  
9/3/2014Donald G PayanEVPSell20,000$2.56$51,200.00  
11/19/2013Bvf Partners P/Ilmajor shareholderSell484,622$2.64$1,279,402.08  
6/7/2013Bvf Partners L P/IlMajor ShareholderBuy32,700$3.47$113,469.00  
9/13/2012Dolly VanceEVPSell4,151$10.43$43,294.93  
(Data available from 1/1/2013 forward)
This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.